Gene Query: DOLK

Dataset Description Geneva Score
Tracing Enhancer Networks using Epigenetic Traits (TENET) 19.98
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 15.06
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 15.05
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 14.54
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.83
RNA expression following TMPRSS11B overexpression or depletion 13.75
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 12.81
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 12.42
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 10.1
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 8.92
Selective suppression of endothelial cytokine production by progesterone receptor 8.92
DRB/GRO-Seq -/+ UV 8.52
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.97
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 7.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 7.68
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.66
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.66
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.44
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.32
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.14
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 6.74
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.55
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 6.4
Biological effect of chronic mistranslation in mammalian cells 6.14
Effect of FGF13 depletion on the H460 cell line 6.13
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 6.13
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 6.13
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.74
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.38
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.31
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.3
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 5.23
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 4.73
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.71
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.51
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.5
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.43
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.43
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.43
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.38
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 4.34
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.18
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.18
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.16
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.16
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.16
Dtx3L and Androgen Signaling in Prostate Cancer 4.08
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 4.06
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.01
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.91
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.9
LNCaP treated with iBET 3.88
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.88
ETV7 and interferon response 3.88
G-quadruplex structures mark human regulatory chromatin 3.87
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.79
Effect of drugs on transcriptomic profiles 3.79
Identification of a LIF-responsive replication-competent human β cell 3.73
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.73
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.65
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.63
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.59
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.5
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.5
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.48
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.46
AUF-1 affected genes in human skin cells 3.45
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.44
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.44
Identification of long noncoding RNAs regulated by p53 3.43
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.4
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.4
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.37
T47D RNA-seq and ChrRNA-seq data 3.37
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.28
AR-independent prostate cancer is sustained through FGF signaling 3.2
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.19
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.19
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.16
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.12
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.09
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.08
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 3.07
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.06
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.06
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.05
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.02
Identification of global XBP1s target gene expression in human prostate cancer cells 2.96
Human HAP1 cells before and after nutrient deprivation 2.95
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 2.95
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.92
STRIPAK directs PP2A activity to promote oncogenic transformation 2.91
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 2.91
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.85
RNA editing in nascent RNA affects pre-mRNA splicing 2.83
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.83
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.82
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 2.81
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.79
PRDM1 inhibits proliferation of human colon cancer organoids 2.76
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.74
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.74
RNA-seq of tumor cells following angiopellosis extravasation 2.74
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.73
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.73
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.73
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.69
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.64
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.64
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.61
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 2.6
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.58
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.56
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.55
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.55
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 2.54
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 2.54
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 2.54
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 2.54
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 2.53
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.52
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.51
Epigenomic conservation of transposable element silencing 2.5
Epigenomic conservation of transposable element silencing [RNA-seq] 2.5
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 2.49
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 2.49
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.47
Transcriptome analysis upon C6orf203 silencing 2.47
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 2.44
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 2.43
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 2.42
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.41
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 2.4
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 2.39
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.35
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.35
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 2.34
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.33
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.3
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 2.28
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 2.28
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 2.27
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.21
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.21
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.21
Energy Metabolism during Anchorage-Independence 2.19
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.18
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 2.17
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 2.17
Gene expression in GBM with Cav3.2 inhibition 2.15
RNAseq of HEK293 cells after Chtop knockdown 2.14
Co-transcriptional loading of RNA export factors shapes the human transcriptome 2.14
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.13
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 2.11
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.07
HNRNPM-regulated splicing dependencies in prostate cancer 2.07
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.07
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.07
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.07
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 2.06
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.05
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.03
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.03
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.03
Effect of PRDM11 depletion in U2932 cells 2.01
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.0
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 1.99
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.99
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.99
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 1.98
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.96
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.93
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.93
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.93
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.92
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.92
HNRNPL and its RNA Targets in Prostate Cancer 1.92
RNA sequencing of GlyH-101-treated MCF-7 cell line 1.9
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.89
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.89
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.89
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.89
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.89
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.89
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.88
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.88
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.88
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.87
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.87
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.87
Chromatin-informed inference of transcriptional programs in gynecologic cancers 1.86
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 1.86
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.85
hTERT promotes cell adhesion and migration independent of telomerase activity 1.84
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.83
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 1.83
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.82
Global analysis of alternative splicing regulated by RBM10 1.8
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.79
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.79
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.78
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.78
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.77
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.77
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 1.77
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.76
Transcriptome analysis of U87 cells upon LINC00152 knockdown 1.75
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.74
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 1.74
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 1.74
Accurate annotation of human protein-coding small open reading frames 1.73
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 1.73
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 1.72
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 1.72
Total RNA sequencing of WT intestinal orgaonids. 1.72
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.71
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.71
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.69
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.69
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.68
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.68
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.68
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.67
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.65
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.65
Lipid degradation promotes prostate cancer cell survival 1.65
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.64
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.64
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.64
Overexpression of NFIB and YBX1 in MCF-7 cells 1.64
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.64
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.62
Endothelial gene expression analysis 1.61
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 1.61
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.6
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.59
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.59
Identification of HOXB13 target genes responsive to BET inhibitors 1.58
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 1.57
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 1.57
Transcriptional effect of ETV1 knockdown in melanoma cells 1.57
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.56
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.55
KLF6-dependent transcription in renal cancer cells 1.54
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.54
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.54
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 1.54
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 1.54
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 1.54
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 1.53
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.53
Functional role of SLIT2 and ROBO1 in trophoblasts 1.53
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 1.52
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 1.52
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.52
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.51
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.51
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.51
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 1.5
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.49
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 1.48
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 1.48
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 1.48
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.48
Glioblastoma stem cells infected by ZIKA virus 1.47
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.46
SLIGRL-induced gene expression changes in NHEK cells 1.44
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 1.44
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 1.44
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.44
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.44
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.43
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.43
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 1.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.42
Novel Targeting of Transcription and Metabolism in Glioblastoma 1.41
miRNAs affected by antagomiR-17 treatment 1.39
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.38
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.38
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.35
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.34
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.34
IL-33 activates tumor stroma to promote intestinal polyposis 1.33
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.33
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.32
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.32
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.29
BASP1 modifies the Tamoxifen response 1.28
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.26
Single-cell analysis of adult human ovary using 10X genomics 1.24
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 1.22
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.22
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.2
Gene expression analysis upon mtDNA depletion 1.2
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.2
Expression profiling of etoposide-induced senescent cells 1.2
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.18
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.17
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 1.15
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.15
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.13
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.12
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.12
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.12
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 1.11
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.09
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.07
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.07
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.07
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.07
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.05
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.04
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 1.04
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.03
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.02
Effect of CHKA knockdown on C4-2 cell transcriptome 1.02
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.02
MRTF activates TEAD-YAP target gene expression 1.0
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 1.0
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.99
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.99
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.98
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.98
RNAseq analysis of ESRP regulated splicing events in prostate cancer 0.98
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.98
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.98
X-Ray induced DNA-Hydroxymethylation changes 0.97
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.97
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.97
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.96
RNA sequencing of human pancreatic cancer cell lines 0.96
DART-seq: an antibody-free method for global m6A detection 0.96
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.95
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.95
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.95
Gene expression profile in breast cancer cell lines using RNA sequencing 0.95
Determining mRNA half-lives on a transcriptome-wide scale 0.94
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.93
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.93
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 0.93
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.93
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.93
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.93
RNA seq comparison between scrambled and shGRP78 cells 0.9
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.9
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.89
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.89
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.89
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.89
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.88
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.88
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.87
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.86
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.86
Co-regulation of splicing by Rbfox1 and hnRNP M 0.85
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.85
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.85
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.83
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.82
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.81
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.81
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.81
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.8
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 0.8
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.79
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.76
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.76
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 0.76
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 0.75
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.74
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.74
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.74
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.72
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.72
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.71
EGR1-controlled transcriptome of T HESCs 0.71
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.71
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.71
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.7
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.69
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.68
RNAseq of cell lines with knocked in ESR1 mutations 0.66
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.65
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.64
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.64
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.64
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 0.61
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.59
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.59
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.58
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.57
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.57
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.56
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.55
RNA-seq differential expression studies: more sequence, or more replication? 0.54
Downregulation of LATS kinases alters p53 to promote cell migration 0.53
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.52
IRF1 regulates IFN dependent and independent gene expression 0.51
Activity-dependent transcriptional changes in human neurons 0.51
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.51
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.5
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.49
Enhancer activation during EGF response 0.49
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.46
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.45
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.44
Transcriptome-wide modulation of splicing by the exon junction complex 0.44
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.44
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.43
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 0.42
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.41
Generation of KRAS signatures using immortalized isogenic lung cells. 0.41
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.4
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.39
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.38
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.37
RNA-seq of shEZH2 cells 0.37
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.34
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.33
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.32
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.31
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.31
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.3
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.3
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.3
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.29
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.27
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.27
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.27
Transcriptome of human white and brown adipose tissue biopsies 0.27
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.27
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.26
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.26
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.25
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 0.24
RNA Seq of HMVEC under hypoxia 0.24
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.24
High-resolution comparative analysis of great ape genomes 0.23
HEK293 TFAM Knockout Expression Study 0.23
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.22
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.22
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.22
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.22
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.22
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.21
CDK4/6 inhibitor resistance in prostate cancer 0.21
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.21
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.2
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.2
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.19
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.19
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.19
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.18
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.18
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.18
RNA-seq analysis upon ARID1B overexpression 0.18
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.17
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.17
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.17
PTHrP overexpression in MCF7 cells 0.17
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.16
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.16
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.16
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.16
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.15
Transposon-based construction of strand-specific RNA-seq libraries 0.15
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.15
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.13
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.11
Effect of nuclear IL-33 on gene expression 0.11
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.11
RNA-Seq of PRMT1 overexpression ECA109 cells 0.1
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 0.09
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.08
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.08
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.08
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.07
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.07
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.06
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.06
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.06
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.04
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.04
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.04
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.04
iPSC derived motor neuron cultures from C9ORF72 carriers 0.03
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.03
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.03
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01
Gene expression changes due to PARP knockdown in human cells 0.01
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.01
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.0
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation